Tag: research

The biennial CRUK Brain Tumour Conference returned to London for 2024.

Researchers in Newcastle have found a key genetic variation in medulloblastomas that may pave the way for more effective targeted treatments.

Our Junior Fellow Dr Spencer Watson and his team at The Ludwig Institute for Cancer Research at the University of Lausanne in Switzerland are researching new ways to treat glioblastoma.

This month we sponsored an event in Manchester which brought together brain tumour experts to talk about new technologies that could improve brain tumour care.

The National Institute for Health and Care Research (NIHR) has announced two new calls for research into brain tumours.

With our funding, researchers in Canada have found key features in different meningiomas that can help predict tumour response to the most common treatments.

Ribociclib – a drug already used to treat breast cancer – may help slow the growth of diffuse hemispheric glioma.

Innovative imaging technology and machine learning developed by our Future Leader, Dr Spencer Watson, helps us understand how glioblastomas respond to treatment.

The guidelines recently published by NICE mean that NHS England will be using dabrafenib and trametinib – the first ever targeted treatment for childhood brain tumours – to treat children whose tumours have a BRAF V600E mutation.

The Ways Ahead project aims to find ways to support, and improve quality of life for those diagnosed with a lower-grade brain tumour. It also explores ways to help friends and family who are supporting those diagnosed.

We are pleased to announce the two researchers who have been awarded our latest Expanding Theories grant!

Research that we funded nearly 20 years ago laid the foundations for last week’s approval of dabrafenib and trametinib to treat childhood gliomas.

Peter Buckle is a patient advocate and has worked with several teams, including the ARISTOCRAT team to champion research and clinical trials.

Living with a lower-grade glioma has a profound impact on those diagnosed, and their families. This is well documented anecdotally but needs to be scientifically addressed so that everyone affected by a brain tumour diagnosis gets the help and support they need.

A new nanosurgical tool – about 500 times thinner than a human hair – could help us understand how glioblastomas become resistant to radio- and chemotherapy. Up until now, no other technology has been able to do this.

In 2019, we awarded £2.96 million to Professor Neil Carragher in collaboration with Cancer Research UK as part of £6 million of funding for vital research into glioblastoma.

Dr Veronica Rendo, a researcher funded by The Brain Tumour Charity, shared the findings of her work at the annual meeting of the Society for Neuro-Oncology.

We are pleased to announce that The Brain Tumour Charity has joined the Cancer Tech Accelerator 3.0 as a new funding partner!

Recent research suggests that there could be a new treatment on the horizon for some children diagnosed with low and high-grade gliomas.

Two of our funded researchers have won awards at the Society for Immunotherapy of Cancer (SITC) annual conference!

We recently attended the NICE 2023 conference and share some of the key takeaways we gathered from the event.

Natalie McKenna was diagnosed with a glioblastoma in 2020. Her tumour later returned, and she went on to support our research funding to find more effective treatments for all brain tumours.

We are pleased to announce the two researchers who have been awarded the Junior Fellowship grant – the second award in our Future Leaders programme!

Zachery Eckworth, now 11 years and living in Hampshire, was just 14 months old when we was diagnosed with an optic nerve glioma.